Steven Nissen has been the target of previous criticism from this corner.
As the famed Cleveland Clinic cardiologist is being mentioned by some as the next head of the FDA, Matthew Mintz wonders how scot-free the white knight really is.
Does his donations of industry-supported honoraria to charities absolve him from conflict, as the Cleveland Clinic alleges? Is his vendetta against Avandia colored from the result of funding from a competing pharmaceutical company?
We’ll never know, but there are more than a few who are watching him closely.
